Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 2
1999 4
2000 5
2001 9
2002 5
2003 6
2004 6
2005 14
2006 10
2007 7
2008 14
2009 12
2010 19
2011 16
2012 26
2013 39
2014 44
2015 48
2016 43
2017 56
2018 58
2019 93
2020 109
2021 105
2022 122
2023 111
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

846 results

Results by year

Filters applied: . Clear all
Page 1
Migraine and sleep disorders: a systematic review.
Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, Hubalek IA, Marchenko Y, Overeem LH, Piroso S, Tkachev A, Martelletti P, Sacco S; European Headache Federation School of Advanced Studies (EHF-SAS). Tiseo C, et al. J Headache Pain. 2020 Oct 27;21(1):126. doi: 10.1186/s10194-020-01192-5. J Headache Pain. 2020. PMID: 33109076 Free PMC article.
Migraine and sleep disorders are common and often burdensome chronic conditions with a high prevalence in the general population, and with considerable socio-economic impact and costs.The existence of a relationship between migraine and sleep disorders has been reco …
Migraine and sleep disorders are common and often burdensome chronic conditions with a high prevalence in the general population, and …
Manual therapies for migraine: a systematic review.
Chaibi A, Tuchin PJ, Russell MB. Chaibi A, et al. J Headache Pain. 2011 Apr;12(2):127-33. doi: 10.1007/s10194-011-0296-6. Epub 2011 Feb 5. J Headache Pain. 2011. PMID: 21298314 Free PMC article. Review.
Migraine occurs in about 15% of the general population. Migraine is usually managed by medication, but some patients do not tolerate migraine medication due to side effects or prefer to avoid medication for other reasons. ...Therefore, any firm conclusion wil …
Migraine occurs in about 15% of the general population. Migraine is usually managed by medication, but some patients do not to …
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials.
Haghdoost F, Puledda F, Garcia-Azorin D, Huessler EM, Messina R, Pozo-Rosich P. Haghdoost F, et al. Cephalalgia. 2023 Apr;43(4):3331024231159366. doi: 10.1177/03331024231159366. Cephalalgia. 2023. PMID: 36855951 Free article. Review.
BACKGROUND: Several novel treatments targeting the calcitonin gene-related peptide pathway have been developed for migraine. We evaluated the efficacy of these medications, including atogepant, rimegepant, erenumab, eptinezumab, fremanezumab, and galcanezumab, for the prev …
BACKGROUND: Several novel treatments targeting the calcitonin gene-related peptide pathway have been developed for migraine. We evalu …
Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review.
Shaterian N, Shaterian N, Ghanaatpisheh A, Abbasi F, Daniali S, Jahromi MJ, Sanie MS, Abdoli A. Shaterian N, et al. Pain Res Manag. 2022 Mar 31;2022:3284446. doi: 10.1155/2022/3284446. eCollection 2022. Pain Res Manag. 2022. PMID: 35401888 Free PMC article. Review.
RESULTS: A total of 24 articles were included in the study. The use of BoNT-A in individuals suffering from chronic migraine (CM) decreases the frequency of migraine attacks per month, pain intensity, medication use, emergency visits, and migraine-related dis …
RESULTS: A total of 24 articles were included in the study. The use of BoNT-A in individuals suffering from chronic migraine (CM) dec …
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R, Katsarava Z, MaassenVanDenBrink A, Martelletti P, Mitsikostas DD, Ornello R, Reuter U, Sanchez-Del-Rio M, Sinclair AJ, Terwindt G, Uluduz D, Versijpt J, Lampl C. Sacco S, et al. J Headache Pain. 2022 Jun 11;23(1):67. doi: 10.1186/s10194-022-01431-x. J Headache Pain. 2022. PMID: 35690723 Free PMC article. Review.
BACKGROUND: A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized controlled trials (RCTs) and real-world evidence have exp …
BACKGROUND: A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene …
The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review.
Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. Hindiyeh NA, et al. Headache. 2020 Jul;60(7):1300-1316. doi: 10.1111/head.13836. Epub 2020 May 25. Headache. 2020. PMID: 32449944 Free PMC article.
BACKGROUND: Migraine is a disabling primary headache disorder often associated with triggers. Diet-related triggers are a common cause of migraine and certain diets have been reported to decrease the frequency of migraine attacks if dietary triggers or patter …
BACKGROUND: Migraine is a disabling primary headache disorder often associated with triggers. Diet-related triggers are a common caus …
What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials.
Woldeamanuel YW, Oliveira ABD. Woldeamanuel YW, et al. J Headache Pain. 2022 Oct 13;23(1):134. doi: 10.1186/s10194-022-01503-y. J Headache Pain. 2022. PMID: 36229774 Free PMC article. Review.
RESULTS: There were 21 published clinical trials that involved a total of 1195 migraine patients with a mean age of 35 years and a female-to-male ratio of 6.7. ...CONCLUSION: Strength training exercise regimens demonstrated the highest efficacy in reducing migraine …
RESULTS: There were 21 published clinical trials that involved a total of 1195 migraine patients with a mean age of 35 years and a fe …
Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.
Yang CP, Liang CS, Chang CM, Yang CC, Shih PH, Yau YC, Tang KT, Wang SJ. Yang CP, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2128544. doi: 10.1001/jamanetworkopen.2021.28544. JAMA Netw Open. 2021. PMID: 34633423 Free PMC article.
IMPORTANCE: New therapeutic classes of migraine-specific treatment have been developed, including 5-hydroxytryptamine1F receptor agonists (lasmiditan) and calcitonin gene-related peptide antagonists (rimegepant and ubrogepant). ...However, the lack of cardiovascular risks …
IMPORTANCE: New therapeutic classes of migraine-specific treatment have been developed, including 5-hydroxytryptamine1F receptor agon …
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A, Peterson J, Coyle D, Skidmore B, Gomes T, Clifford T, Wells G. Cameron C, et al. Headache. 2015 Jul-Aug;55 Suppl 4:221-35. doi: 10.1111/head.12601. Epub 2015 Jul 14. Headache. 2015. PMID: 26178694 Review.
BACKGROUND: Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of triptans among each other and vs non-triptan migraine treatments. ...METHODS: The Cochrane Library, MEDLINE, and EMBASE were se …
BACKGROUND: Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative effica …
Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis.
Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Bae JY, et al. Medicina (Kaunas). 2021 Dec 28;58(1):44. doi: 10.3390/medicina58010044. Medicina (Kaunas). 2021. PMID: 35056352 Free PMC article. Review.
Randomized controlled studies (RCTs) using CBT as an intervention for migraine were included. The primary outcome of this study was to determine the frequency of migraines and the intensity of migraines on Visual Analog Scale (VAS), the frequency of drug use, Migraine …
Randomized controlled studies (RCTs) using CBT as an intervention for migraine were included. The primary outcome of this study was t …
846 results